 | Up a level |
2022
French, Christopher A., Cheng, Michael L., Hanna, Glenn J., DuBois, Steven G., Chau, Nicole G., Hann, Christine L., Storck, Simone, Salgia, Ravi, Trucco, Matteo, Tseng, Jennifer, Stathis, Anastasios, Piekarz, Richard, Lauer, Ulrich M., Massard, Christophe, Bennett, Kelly, Coker, Shodeinde, Tontsch-Grunt, Ulrike, Sos, Martin L., Liao, Sida, Wu, Catherine J., Polyak, Kornelia, Piha-Paul, Sarina A. and Shapiro, Geoffrey I. (2022). Report of the First International Symposium on NUT Carcinoma. Clin. Cancer Res., 28 (12). S. 2493 - 2506. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265
2019
Munster, Pamela, Mita, Monica, Mahipal, Amit, Nemunaitis, John, Massard, Christophe, Mikkelsen, Tom, Cruz, Cristina, Paz-Ares, Luis, Hidalgo, Manuel, Rathkopf, Dana, Blumenschein, George, Jr., Smith, David C., Eichhorst, Barbara, Cloughesy, Tim, Filvaroff, Ellen H., Li, Shaoyi, Raymon, Heather, de Haan, Hans, Hege, Kristen and Bendell, Johanna C. (2019). First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy. Cancer Manag. Res., 11. S. 10463 - 10477. ALBANY: DOVE MEDICAL PRESS LTD. ISSN 1179-1322
2016
Munster, Pamela N., Mahipal, Amit, Nemunaitis, John J., Mita, Monica M., Paz-Ares, Luis G., Massard, Christophe, Mikkelsen, Tom, Cruz, Cristina, Rathkopf, Dana E., Blumenschein, George R., Hidalgo, Manuel, Smith, David C., Eichhorst, Barbara, Cloughesy, Timothy Francis, Garrick, Brett, Trowe, Torsten, Filvaroff, Ellen, Hege, Kristen and Bendell, Johanna C. (2016). Phase I trial of a dual TOR kinase and DNA-PK inhibitor (CC-115) in advanced solid and hematologic cancers. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755